Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "IND"

7614 News Found

Industrial AI takes center stage at ARC Industry Leadership India Forum 2026
Supply Chain | May 08, 2026

Industrial AI takes center stage at ARC Industry Leadership India Forum 2026

The event will bring together industrial leaders, technology providers, and policymakers to discuss real-world Industrial AI applications in Bangalore


Illumina showcases multi-omics potential to advance precision medicine in India
Biopharma | May 08, 2026

Illumina showcases multi-omics potential to advance precision medicine in India

The company highlights role of integrated genomics and multi-omics research at the Illumina Multiomics Summit India 2026 held in New Delhi and Bengaluru


Uttar Pradesh poised to become India’s premier healthcare and medical device hub: Dr. G.N. Singh
Policy | May 08, 2026

Uttar Pradesh poised to become India’s premier healthcare and medical device hub: Dr. G.N. Singh

Former DCGI and now advisor to UP CM highlights medical device growth, healthcare expansion, and investment opportunities in the state


Sanofi India partners with NHM MP to expand NCD, rare disease services
News | May 08, 2026

Sanofi India partners with NHM MP to expand NCD, rare disease services

The partnership will focus on diabetes and NCD awareness, rare disease screening, and deployment of mobile medical units


Free HLA typing for children with thalassaemia launched in India
Healthcare | May 07, 2026

Free HLA typing for children with thalassaemia launched in India

The initiative by DKMS Foundation India is for below 12 years children suffering from transfusion-dependent thalassemia


Safic-Alcan expands in India with majority stake in SA Ingredients
News | May 07, 2026

Safic-Alcan expands in India with majority stake in SA Ingredients

The deal brings SAI — a key distributor serving pharmaceutical and nutraceutical manufacturers — into the Safic-Alcan Group’s expanding Asia footprint


Bayer strikes $2.45 billion deal for breakthrough blindness drug developer Perfuse Therapeutics
News | May 07, 2026

Bayer strikes $2.45 billion deal for breakthrough blindness drug developer Perfuse Therapeutics

The acquisition gives Bayer full rights to PER-001, an experimental therapy now in Phase II clinical trials for Glaucoma and Diabetic Retinopathy


Danone India and UP govt. introduce Iron-Anthem to drive anemia awareness
Policy | May 07, 2026

Danone India and UP govt. introduce Iron-Anthem to drive anemia awareness

The 40-second film brings children to the forefront of the narrative


Eli Lilly unveils $4.5 bn Indiana expansion
News | May 07, 2026

Eli Lilly unveils $4.5 bn Indiana expansion

The investment will upgrade and expand production capabilities at Lilly Lebanon API and Lilly Lebanon Advanced Therapies


Indegene named leader in ISG provider lens 2026 for life sciences digital commercial operations
Digitisation | May 05, 2026

Indegene named leader in ISG provider lens 2026 for life sciences digital commercial operations

The ISG assessment highlights Indegene’s deep domain expertise, proprietary technology stack, and expanding use of AI and GenAI to drive more integrated, data-led commercial execution across the life sciences value chain